Abstract
A monoclonal antibody, H317, has been used for the sensitive and specific detection of placental-type alkaline phosphatase (PLAP) in sera, solubilized tissue extracts and fixed tumour tissue sections from patients representing a variety of ovarian tumours. PLAP was detected in over 30% of these sera and in most solubilized tumour tissue extracts. There was no association between circulating PLAP levels and either tissue extract levels or immunohistological staining of ovarian tumour tissue sections with H317. Nevertheless, immunohistology demonstrated the heterogeneity of cellular localization of PLAP within different tumours, and can often be of value in localizing tumour tissue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
McDicken, I., McLaughlin, P., Tromans, P. et al. Detection of placental-type alkaline phosphatase in ovarian cancer. Br J Cancer 52, 59–64 (1985). https://doi.org/10.1038/bjc.1985.149
Issue Date:
DOI: https://doi.org/10.1038/bjc.1985.149
This article is cited by
-
Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours
Virchows Archiv A Pathological Anatomy and Histopathology (1990)
